The trademark application PHIVEA was filed by GMendel ApS, a corporation established under the laws of the Kingdom of Denmark (the "Applicant"). The application was published for oppositions on September 23, 2021, and it was registered by office on January 5, 2022 without any oppositions.
The application was filed in Greek (English was selected as the second language).
Goods And Services
The mark was filed in class 9 with following description of goods:
Application software
Downloadable electronic publications
Audio visual, audio, video and multimedia materials
All of the aforesaid goods exclusively relating to the area of healthcare and in respect of Artificial Intelligence and Genomics Research for Rare Diseases Difficult to Diagnose and Geriatric care.
The mark was filed in class 42 with following description of goods:
Scientific and technological services and research and services relating thereto, industrial analysis and research services
Design and evelopment of computer hardware, software
Hosting web portals
Clinical research
Clinical trials
Biomedical research services
Research in the field of artificial knowledge
Providing artificial intelligence computer programs on data networks
Platforms for artificial intelligence as software as a service
Information, advisory and consultancy services relating to the aforesaid
All of the aforesaid services exclusively relating to the area of healthcare and in respect of Artificial Intelligence and Genomics Research for Rare Diseases Difficult to Diagnose and Geriatric Care.
The mark was filed in class 44 with following description of goods:
Medical diagnostic services
Alternative medicine services
Health care services
Medical assistance
Medical consultation
Health care consultancy services [medical]
Medical analysis for the diagnosis and treatment of persons
Medical testing services relating to the diagnosis and treatment of disease
Health assessment surveys
Pharmacists' services to make up prescriptions
Medical advisory services
All aforesaid services relating to Artificial Intelligence and Genomics Research for Rare Diseases Difficult to Diagnose and Geriatric Care.